首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1186738

基因組測序市場：現狀分析與預測（2022-2028）

Genome Sequencing Market: Current Analysis and Forecast (2022-2028)

出版日期: 2022年12月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 168 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

基因組測序的市場規模預計將在 2022 年至 2028 年間以約 13% 的複合年增長率增長。 DNA測序技術已經從第一代發展到第三代。由於其特性，DNA 測序系統得到了普及，並有望對 DNA 測序市場產生積極影響。由於對基於 NGS 的診斷的重視以及全球癌症發病率的迅速增加，對基因組測序的需求不斷增加。

本報告調查了全球基因組測序市場，提供了市場概況、產品趨勢、技術、應用、最終用戶、地區以及進入市場的公司概況。

內容

第一章市場介紹

第 2 章基因組測序市場研究方法

第三章市場總結

第 4 章執行摘要

第 5 章 COVID-19 的影響

第 6 章全球基因組測序市場收入，2020-2028

第 7 章產品市場洞察

消耗品
設備
服務

第 8 章技術市場洞察

桑格測序
下一代測序
聚合□鏈反應
微陣列
其他

第 9 章應用市場洞察

腫瘤學
生殖醫學
複雜疾病研究
藥物發現和開發
精準醫學
農業和動物研究
其他

第 10 章最終用戶的市場洞察

學術研究中心
製藥和生物技術公司
消費者基因組服務提供商
政府機構
其他

第 11 章按地區劃分的市場洞察

北美基因組測序市場
歐洲基因組測序市場
亞太基因組測序市場
世界其他地區的基因組測序市場

第 12 章基因組測序市場動態

市場驅動力
市場挑戰
影響分析

第 13 章基因組測序的市場機會

第 14 章基因組測序市場趨勢和洞察

第15章需求側與供給側分析

第 16 章價值鏈分析

第十七章價格分析

第 18 章戰略洞察

第 19 章衝突場景

第20章公司簡介

Agilent Technologies Inc
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Qiagen NV
BGI Genomics Co Ltd
Oxford Nanopore Technologies PLC
Macrogen Inc
PerkinElmer, Inc.
Pacific Biosciences of California Inc
Bio-Rad Laboratories, Inc.

第21章免責事項

簡介目錄

Product Code: UMME211556

The genome sequencing market is expected to register a CAGR of approx. 13% over the period of 2022-2028. The process of mapping and sequencing a person's individual DNA is known as genome sequencing. The term "genome" refers to the complete blueprint of a person's human body. A person's genes, which are a bundle of DNA, can cause a disease or increase the likelihood of disease. Genome sequencing helps to identify any significant differences in the genes, which can increase the likelihood of disease. DNA sequencing is inexpensive, has high accuracy and speed, and can produce results from small samples. DNA sequencing technologies have advanced from the first to the third generation. Because of their features, DNA sequencing systems have gained traction, which may have a positive impact on the DNA sequencing market. The growing demand for genome sequencing can be attributed to the growing emphasis on NGS-based diagnostics and surging incidences of cancer across the globe. For instance, the number of cancer cases in the US will increase 49% each year, from 1,534,500 in 2015 to 2,286,300 in 2050, with the largest percentage increase among adults aged ≥75 years, as per the predictions by CDC. Owing to the glaring statistics the increase in cancer prevalence has created a buzz among biotechnology and pharmaceutical companies for investing in the development of effective and reliable diagnostic tools which boosts the demand for genome sequencing across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the genome sequencing market is anticipated to grow on account of the rapid advancements in sequencing technology and bioinformatics. In addition, changes in lifestyle and various health-related issues drive market growth. However, some of the restraints in the market including the Lack of trained professionals and the high cost of establishing and maintaining a sequencing facility are impeding the growth of this market all over the world.

Agilent Technologies Inc; Thermo Fisher Scientific, Inc.; Illumina, Inc.; Qiagen NV; BGI Genomics Co Ltd; Oxford Nanopore Technologies PLC; Macrogen Inc; PerkinElmer, Inc.; Pacific Biosciences of California Inc; Bio-Rad Laboratories, Inc are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst product, the consumables category led the market in 2020 with the highest market share"

Based on the product, the genome sequencing market is segmented into consumables, instruments, and services. The consumables segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. A larger share of the segment is attributed to the broad availability of reagents and kits to address all stages of library construction, including DNA fragmentation, enrichment, adapter ligation, amplification, and quality control. The majority of these tools support low-input and formalin-fixed specimens and have streamlined and simplified workflows, ready-to-use components, and components.

"Amongst technology, the next-generation sequencing category led the market in 2020 with the highest market share"

Based on the technology, the market is fragmented into sanger sequencing, next-generation sequencing, polymerase chain reaction, microarrays, and others. The next-generation sequencing segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. The rapid advancements in these technologies, combined with the decreasing cost of sequencing, have made genome sequencing faster, more affordable, and more accurate. Additionally, the use of NGS technology for routine clinical diagnostic tests is growing, especially in light of the COVID-19 infection pandemic, which benefits the segment's revenue share.

"Amongst applications, the oncology category is expected to hold considerable market share during the forecast period"

Based on the application, the market is fragmented into oncology, reproductive health, complex disease research, drug discovery and development, precision medicine, agriculture and animal research, and others. The oncology segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. The technology has enormous potential for clinical research as well as the creation of cancer diagnostics and therapeutics. Recent advancements in NGS technology have shown its potential as a high-throughput, low-cost method for identifying and characterizing clinically useful genetic variants across a wide range of genes quickly and in a single test.

"Amongst end-user, the academic & research centers category is expected to witness considerable CAGR during the forecast period"

Based on the end-user, the market is fragmented into academic & research centers, pharmaceutical and biotechnology companies, consumer genomic service providers, government institutes, and others. The academic & research centers segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Sanger technology and NGS are widely used in academic and institutional research projects because of their widespread acceptance. Additionally, an increase in funding and investment initiatives boosts the demand for DNA sequencing products in these organizations, leading to a higher revenue share.

"North America to witness significant growth during the forecast period"

For a better understanding of the market adoption of the genome sequencing, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the genome sequencing industry owing to the continuous technological developments by key players, high investment in R&D, availability of technologically advanced healthcare infrastructure, rising need for personalized medicine and the presence of several government initiatives in the U.S. and Canada supports research in drug development and treatment of cancer.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global genome sequencing market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Genome Sequencing Market

2 2.2. Research Methodology of the Genome Sequencing Market

2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE GENOME SEQUENCING MARKET

6 GLOBAL GENOME SEQUENCING MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

7.1. Consumables
7.2. Instruments
7.3. Services

8 MARKET INSIGHTS BY TECHNOLOGY

8.1. Sanger Sequencing
8.2. Next-Generation Sequencing
8.3. Polymerase Chain Reaction
8.4. Microarrays
8.5. Others

9 MARKET INSIGHTS BY APPLICATION

9.1. Oncology
9.2. Reproductive Health
9.3. Complex Disease Research
9.4. Drug Discovery and Development
9.5. Precision Medicine
9.6. Agriculture and Animal Research
9.7. Others

10 MARKET INSIGHTS BY END-USERS

10.1. Academic & Research Centers
10.2. Pharmaceutical and Biotechnology Companies
10.3. Consumer Genomic Service Providers
10.4. Government Institutes
10.5. Others

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA GENOME SEQUENCING MARKET
- 11.1.1 U.S.
- 11.1.2 Canada
- 11.1.3 Rest of North America
11.2 EUROPE GENOME SEQUENCING MARKET
- 11.2.1 Germany
- 11.2.2 U.K.
- 11.2.3 France
- 11.2.4 Spain
- 11.2.5 Italy
- 11.2.6 Rest of Europe
11.3 ASIA PACIFIC GENOME SEQUENCING MARKET
- 11.3.1 China
- 11.3.2 Japan
- 11.3.3 India
- 11.3.4 Australia
- 11.3.5 Rest of Asia Pacific
11.4 REST OF THE WORLD GENOME SEQUENCING MARKET